# A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE)

> **NCT04524364** · NA · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 272 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Pulsed Field Ablation (PFA) Therapy

## Key facts

- **NCT ID:** NCT04524364
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-23
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-09
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524364, "A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04524364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*